CDK4 and colorectal cancer: Gelbert et al. reported that treatment of colorectal cancer and acute myeloid leukemia cells with LY2835219, a CDK4/6 inhibitor, resulted in G1 phase arrest, cell apoptosis, and further suppression of tumor growth in tumor xenografts [30].